COLLEEN HERR: Open Payments
NPI 1194093476 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 57 payments from 16 companies in 2025. Trend: 2023 $1,333 · 2024 $1,659 · 2025 $1,487
Food & beverage: $1,487
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $282 |
| ABBVIE INC. | 9 | $220 |
| Madrigal Pharmaceuticals | 7 | $167 |
| PFIZER INC. | 7 | $163 |
| Janssen Biotech, Inc. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Aimmune Therapeutics, Inc. | 5 | $98 |
| Novo Nordisk Inc | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Ardelyx, Inc. | 2 | $50 |
Products named: DUPIXENT, REZDIFFRA, TREMFYA, ENTYVIO, ZENPEP, VELSIPITY, XELJANZ, Wegovy.
Industry payments across CA — which companies pay providers there.
